Utama › Penyakit Paru Interstisial › Utah › Salt Lake City
Kajian klinikal Penyakit Paru Interstisial di Salt Lake City, UT
9 kajian untuk Penyakit Paru Interstisial sedang mencari peserta di lokasi dalam dan sekitar Salt Lake City (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
Mengambil pesertaFasa 3
- University of Utah Health Sciences Center, Salt Lake City
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Mengambil pesertaFasa 3
- USA025, Salt Lake City
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
Mengambil pesertaFasa 3
- GSK Investigational Site, Salt Lake City
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Mengambil pesertaFasa 2
- University of Utah, Salt Lake City
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Mengambil peserta
- University of Utah, Salt Lake City
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Mengambil pesertaKajian pemerhatian
- University of Utah Health, Salt Lake City
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Mengambil pesertaKajian pemerhatian
- University of Utah, Salt Lake City
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Mengambil pesertaFasa 3
- University of Utah Health, Salt Lake City
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
Mengambil pesertaFasa 2
- aTyr Investigative Site, Salt Lake City
Kajian Penyakit Paru Interstisial di bandar lain
- New York City, NY18 kajian
- Philadelphia, PA16 kajian
- Los Angeles, CA14 kajian
- Charleston, SC13 kajian
- Kansas City, KS13 kajian
- Durham, NC13 kajian
- Chicago, IL12 kajian
- Houston, TX12 kajian
- Aurora, CO11 kajian
- Ann Arbor, MI11 kajian
- Dallas, TX9 kajian
- Boston, MA9 kajian
Kajian lain di Salt Lake City
- Kanser Paru-paru Bukan Sel Kecil31 kajian
- Kanser (semua jenis)27 kajian
- Kanser Payudara27 kajian
- Kanser Kolorektal22 kajian
- Kanser Paru-paru21 kajian
- Melanoma21 kajian
- Mieloma Pelbagai21 kajian
- Kanser Metastatik20 kajian
- Kanser Ovari19 kajian
- Obesiti18 kajian
- Leukemia Mieloid Akut17 kajian
- Kegagalan Jantung17 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.